Andrew Allen

Board Member at TCR2 Therapeutics - Cambridge, MA, US

Andrew Allen's Contact Details
HQ
617-949-5200
Location
San Francisco, California
Company
TCR2 Therapeutics
Andrew Allen's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Andrew Allen
Andrew Allen currently works for TCR2 Therapeutics.
Andrew Allen's role at TCR2 Therapeutics is Board Member.
Andrew Allen's email address is ***@tcr2.com. To view Andrew Allen's full email address, please signup to ConnectPlex.
Andrew Allen works in the BioTech/Drugs industry.
Andrew Allen's colleagues at TCR2 Therapeutics are Shawn Tomasello, Kurtis Carlisle, Aaron Vernon, Emily Diaz, Shinji Oyama, Dhiral Shah, Amanda Marie Kennedy and others.
Andrew Allen's phone number is 617-949-5200
See more information about Andrew Allen